Peptidyl-lysine monomethylation

pathway activity — cross-omics
GO:0018026Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Peptidyl-lysine monomethylation pathway is significantly associated with the RNA expression of multiple genes, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are BHLHE41, DEDD, and UGP2, each associated with the pathway in up to 3 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Peptidyl-lysine monomethylation activity versus BHLHE41 in LSCC (Pearson r = -0.20).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCBHLHE41 →-0.692-0.514<.001.00533
UCECDEDD →+0.313+0.427.008.00533
GBMUGP2 →-0.333-0.526<.001.00133
GBMHNRNPA1P66 →-0.312-0.493.001.00333
GBMHPF1 →-0.366-0.691<.001<.00133
PDACNBDY →-0.181-0.275.009.00432
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0018026 vs BHLHE41 — LSCC

Per-sample scatter of Peptidyl-lysine monomethylation activity vs BHLHE41 in LSCC.

Explore this scatter interactively →

Exploration